Importantly, as SOX2 play crucial roles in tumor-resistance or anti-apoptotic responses to standard therapies, our studies indicate that anti-SOX2 targeting agent(s) could further be tested for melanoma chemoprevention. The gene discussed is SOX2; the disease is melanoma.